Gene · 10148
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human granzyme B regulatory B cells prevent effector CD4+CD25- T cell proliferation through a mechanism dependent from lymphotoxin alpha. | Front Immunol | 2023 | 37588598 | PubTator, text mining | PubMed |
| Endothelial Cell Response in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children. | Int J Mol Sci | 2023 | 37569694 | PubTator, text mining | PubMed |
| T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment. | Int J Mol Sci | 2023 | 37569479 | PubTator, text mining | PubMed |
| Predicting response to immunotherapy in gastric cancer via assessing perineural invasion-mediated inflammation in tumor microenvironment. | J Exp Clin Cancer Res | 2023 | 37563649 | PubTator, text mining | PubMed |
| Interleukin-34-NF-κB signaling aggravates myocardial ischemic/reperfusion injury by facilitating macrophage recruitment and polarization. | EBioMedicine | 2023 | 37556943 | PubTator, text mining | PubMed |
| METTL14‑mediated RNA methylation in digestive system tumors. | Int J Mol Med | 2023 | 37539726 | PubTator, text mining | PubMed |
| Plasmodium falciparum infection reshapes the human microRNA profiles of red blood cells and their extracellular vesicles. | iScience | 2023 | 37534175 | PubTator, text mining | PubMed |
| Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. | J Hematol Oncol | 2023 | 37533128 | PubTator, text mining | PubMed |
| Modulation of immunity by tryptophan microbial metabolites. | Front Nutr | 2023 | 37521424 | PubTator, text mining | PubMed |
| Roles of Extracellular Vesicles on the Progression and Metastasis of Hepatocellular Carcinoma. | Cells | 2023 | 37508544 | PubTator, text mining | PubMed |
| Integration analysis of senescence-related genes to predict prognosis and immunotherapy response in soft-tissue sarcoma: evidence based on machine learning and experiments. | Front Pharmacol | 2023 | 37497116 | PubTator, text mining | PubMed |
| Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer. | Aging (Albany NY) | 2023 | 37494663 | PubTator, text mining | PubMed |
| Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma. | J Mol Neurosci | 2023 | 37488455 | PubTator, text mining | PubMed |
| Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape. | Innovation (Camb) | 2023 | 37485079 | PubTator, text mining | PubMed |
| Interleukins (IL-23 and IL-27) serum levels: Relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate. | Heliyon | 2023 | 37484355 | PubTator, text mining | PubMed |
| Recombinant protein EBI3 attenuates Clonorchis sinensis-induced liver fibrosis by inhibiting hepatic stellate cell activation in mice. | Parasit Vectors | 2023 | 37480105 | PubTator, text mining | PubMed |
| Goat milk extracellular vesicles: immuno-modulation effects on porcine monocyte-derived macrophages in vitro. | Front Immunol | 2023 | 37469517 | PubTator, text mining | PubMed |
| A spatially resolved timeline of the human maternal-fetal interface. | Nature | 2023 | 37468587 | PubTator, text mining | PubMed |
| Optimization of differentiation and transcriptomic profile of THP-1 cells into macrophage by PMA. | PLoS One | 2023 | 37459313 | PubTator, text mining | PubMed |
| Liang-Ge-San: a classic traditional Chinese medicine formula, attenuates acute inflammation via targeting GSK3β. | Front Pharmacol | 2023 | 37456759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10148/papers?page=8